ABL
Abbott Laboratories · GETTEX:ABL
97.99 EUR−0.5200 −0.53%
Abbott Laboratories (GETTEX:ABL) last traded at 97.99 EUR, down 0.53% on the day. Over the past year the stock is down 8.42%. Its 52-week range is 69.65 to 113.76. It is in the Health Technology sector (Medical Specialties).
Key statistics
Open98.51
Day range97.19 – 98.82
52-week range69.65 – 113.76
Volume174
Average volume (10 days)600
Market cap (USD)190.62 B
P/E40.98
EPS (TTM) (USD)2.71
Dividend yield2.29%
Beta (1 year)0.3618
Revenue (TTM) (USD)48.23 B
Employees115.00 K
Performance
+4.13%1 week
+13.57%1 month
+7.27%3 months
+33.32%6 months
−8.51%Year to date
−8.42%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Abbott Touts Favorable Outcomes In Cardiovascular Device TrialsBenzinga · 02 Nov 2026
- Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
- HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
- Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
- Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
- Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
- Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
- Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.